Compare WYETH LTD with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs DIVIS LABORATORIES - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD DIVIS LABORATORIES WYETH LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 27.7 35.1 78.9% View Chart
P/BV x 5.3 6.5 81.8% View Chart
Dividend Yield % 1.3 0.9 136.3%  

Financials

 WYETH LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
DIVIS LABORATORIES
Mar-19
WYETH LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0441,639 63.7%   
Low Rs8181,115 73.4%   
Sales per share (Unadj.) Rs298.6186.3 160.2%  
Earnings per share (Unadj.) Rs57.251.0 112.3%  
Cash flow per share (Unadj.) Rs58.457.3 101.9%  
Dividends per share (Unadj.) Rs17.0016.00 106.3%  
Dividend yield (eoy) %1.81.2 157.1%  
Book value per share (Unadj.) Rs249.5261.8 95.3%  
Shares outstanding (eoy) m22.72265.47 8.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.17.4 42.2%   
Avg P/E ratio x16.327.0 60.2%  
P/CF ratio (eoy) x15.924.0 66.4%  
Price / Book Value ratio x3.75.3 71.0%  
Dividend payout %29.731.4 94.6%   
Avg Mkt Cap Rs m21,157365,592 5.8%   
No. of employees `0000.511.8 4.2%   
Total wages/salary Rs m4005,423 7.4%   
Avg. sales/employee Rs Th13,787.44,175.1 330.2%   
Avg. wages/employee Rs Th813.0457.7 177.6%   
Avg. net profit/employee Rs Th2,643.31,141.8 231.5%   
INCOME DATA
Net Sales Rs m6,78349,463 13.7%  
Other income Rs m3531,556 22.7%   
Total revenues Rs m7,13651,019 14.0%   
Gross profit Rs m1,61718,718 8.6%  
Depreciation Rs m271,689 1.6%   
Interest Rs m635 15.7%   
Profit before tax Rs m1,93818,551 10.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6325,023 12.6%   
Profit after tax Rs m1,30113,527 9.6%  
Gross profit margin %23.837.8 63.0%  
Effective tax rate %32.627.1 120.5%   
Net profit margin %19.227.3 70.1%  
BALANCE SHEET DATA
Current assets Rs m6,98446,501 15.0%   
Current liabilities Rs m2,0568,468 24.3%   
Net working cap to sales %72.676.9 94.5%  
Current ratio x3.45.5 61.9%  
Inventory Days Days99131 75.9%  
Debtors Days Days2486 27.9%  
Net fixed assets Rs m24425,797 0.9%   
Share capital Rs m227531 42.8%   
"Free" reserves Rs m5,44168,962 7.9%   
Net worth Rs m5,66869,493 8.2%   
Long term debt Rs m250-   
Total assets Rs m7,90180,383 9.8%  
Interest coverage x353.3531.0 66.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 139.5%   
Return on assets %16.516.9 98.0%  
Return on equity %22.919.5 117.9%  
Return on capital %34.026.7 127.3%  
Exports to sales %0.20-   
Imports to sales %36.324.6 147.5%   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,46512,187 20.2%   
Fx inflow Rs m1541,238 0.0%   
Fx outflow Rs m2,67712,405 21.6%   
Net fx Rs m-2,66228,833 -9.2%   
CASH FLOW
From Operations Rs m9239,543 9.7%  
From Investments Rs m317-6,854 -4.6%  
From Financial Activity Rs m-481-2,459 19.6%  
Net Cashflow Rs m759230 330.6%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 11.8 95.8%  
FIIs % 7.2 19.0 37.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.2 176.7%  
Shareholders   21,978 31,796 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  NATCO PHARMA  ELDER PHARMA  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS